Deborah G Hirtz1, Peter R Gilbert, Cindy M Terrill
1National Institute of Neurological Disorders and Stroke/National Institutes of Health, Bethesda, Maryland 20892, USA. hirtzd@ninds.nih.gov
Pediatric drug metabolism differs from adults, necessitating clinical trials for safe and effective treatments in children. This ensures accurate dosing and minimizes unpredictable adverse events in pediatric populations.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: